title: Cytomorphology of childhood lymphoblastic leukaemia: a prospective study of 2000 patients. United Kingdom Medical Research Council's Working Party on Childhood Leukaemia.
abstract: Blast cell morphology of children with lymphoblastic leukaemia (ALL) entering two national multicentre trials was prospectively reviewed by three haematologists to define the clinical importance of (a) French-American-British (FAB) classification, (b) the presence of cytoplasmic vacuoles, and (c) the presence of 'hand-mirror' cells. Of 2135 evaluable children, 1907 (89%) had FAB L1 morphology and 228 (11%) L2. (L3 patients were not eligible for the trials in question). L2 patients more frequently had residual disease 14 d after starting treatment and had a significantly inferior disease-free survival, but not if the analysis was stratified for age, sex and diagnostic white cell count (WBC). 627 (29%) had blast cells with cytoplasmic vacuoles, and showed a significant survival advantage over the remainder. Vacuoles were positively associated with a low WBC, age range 1-6 years and blast cell positivity for CD10, but their benign influence was apparent even when these variables were taken into account. 'Hand-mirror' (HM) cells were only studied in UKALL X, and were noted in 316/1402 (23%) children. There appeared to be an inverse correlation between HM cells and cytoplasmic vacuoles and a weak association with T-cell immunophenotype, but no prognostic significance was evident. FAB classification appears to be of less prognostic importance than has previously been supposed, though L2 disease is more resistant to current remission induction regimens. Hand-mirror cells may be more common in T-ALL, but are seen in all types and are not related to prognosis. Cytoplasmic vacuoles are predictive of a good response to current therapeutic schedules even allowing for other prognostic variables, and are the single most important morphological feature relating to prognosis in childhood ALL.
authors.affiliation: Department of Haematology, Children's Hospital, Sheffield.
authors.forename: J S
authors.initials: JS
authors.lastname: Lilleyman
authors.forename: I M
authors.initials: IM
authors.lastname: Hann
authors.forename: R F
authors.initials: RF
authors.lastname: Stevens
authors.forename: S M
authors.initials: SM
authors.lastname: Richards
authors.forename: O B
authors.initials: OB
authors.lastname: Eden
authors.forename: J M
authors.initials: JM
authors.lastname: Chessells
authors.forename: C C
authors.initials: CC
authors.lastname: Bailey
mesh_terms: D000293:Adolescent; D001752:Blast Crisis / Q000473:pathology; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D016130:Immunophenotyping; D007223:Infant; D007958:Leukocyte Count; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000145:classification / Q000453:epidemiology* / Q000473:pathology*; D011379:Prognosis; D011446:Prospective Studies; D006113:United Kingdom / Q000453:epidemiology; D014617:Vacuoles / Q000648:ultrastructure